These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6134861)

  • 1. [Comparative studies of initial pressure reduction using 0.3% metipranolol and 0.25% timolol in eyes with wide-angle glaucoma].
    Merté HJ; Stryz JR; Mertz M
    Klin Monbl Augenheilkd; 1983 Apr; 182(4):286-9. PubMed ID: 6134861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mid-term results of a double-blind study comparing metipranolol to timolol in the treatment of primary open-angle glaucoma].
    Ecoffet M; Demailly P
    J Fr Ophtalmol; 1987; 10(6-7):451-4. PubMed ID: 2891740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Metipranolol 0.1%: effect of a single dose on the nycthemeral pressure curve in an eye with chronic primary open-angle glaucoma].
    Demailly P; Lecherpie F
    J Fr Ophtalmol; 1987; 10(6-7):447-9. PubMed ID: 2891739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.
    Martínez A; Sánchez M
    Clin Ther; 2008 Jun; 30(6):1120-34. PubMed ID: 18640468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Metipranolol--a new beta-blocker].
    Kruse W
    Klin Monbl Augenheilkd; 1983 Jun; 182(6):582-4. PubMed ID: 6135820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A blind randomised cross-over trial comparing metipranolol 0.3% with timolol 0.25% in open-angle glaucoma: a pilot study.
    Mills KB; Wright G
    Br J Ophthalmol; 1986 Jan; 70(1):39-42. PubMed ID: 2868753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of levobunolol eyedrops on trabecular outflow of aqueous humor in chronic simple glaucoma].
    Călugăru M
    Klin Monbl Augenheilkd; 1989 Mar; 194(3):164-9. PubMed ID: 2657200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of timolol therapy on outflow facility.
    Sonntag JR; Brindley GO; Shields MB
    Invest Ophthalmol Vis Sci; 1978 Mar; 17(3):293-6. PubMed ID: 627467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 12-month, randomized, double-masked study comparing latanoprost with timolol in pigmentary glaucoma.
    Mastropasqua L; Carpineto P; Ciancaglini M; Gallenga PE
    Ophthalmology; 1999 Mar; 106(3):550-5. PubMed ID: 10080213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol: a randomized, observer-masked multicenter study in patients with open-angle glaucoma. Italian Latanoprost Study Group.
    Bucci MG
    J Glaucoma; 1999 Feb; 8(1):24-30. PubMed ID: 10084271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative studies of the pressure-lowering effect of timolol and phospholine iodide (author's transl)].
    Christakis C; Mangouritsas N
    Klin Monbl Augenheilkd; 1981 Sep; 179(3):197-200. PubMed ID: 7300230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prepared association of metipranolol 0.1% + pilocarpine 2% and of timolol 0.5% + pilocarpine 2%. Comparison of clinical efficacy and topical tolerability in the treatment of patients affected by POAG tonometrically uncontrolled with beta-blocker alone (two-centre study).
    Boles Carenini B; Brogliatti B; Dorigo MT; Vadalà G; Protti R; Bellone A
    Acta Ophthalmol Scand Suppl; 1997; (224):54-5. PubMed ID: 9589740
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ocular hypotensive effect of low doses of timolol].
    Erichev VP; Salminen L; Maĭchuk IuF
    Vestn Oftalmol; 1987; 103(6):15-7. PubMed ID: 3328383
    [No Abstract]   [Full Text] [Related]  

  • 14. The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patients.
    Costagliola C; Parmeggiani F; Antinozzi PP; Caccavale A; Cotticelli L; Sebastiani A
    Exp Eye Res; 2005 Nov; 81(5):610-5. PubMed ID: 15949795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Metipranolol 0.1% and pilocarpine 2% as a fixed combination compared to each substance alone in the treatment of glaucoma. A controlled, randomized clinical study comparing the intraindividual effects and tolerance].
    Scharrer A; Ober M
    Klin Monbl Augenheilkd; 1986 Dec; 189(6):450-5. PubMed ID: 2882046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the effects of dorzolamide/timolol fixed combination versus latanoprost on intraocular pressure and pulsatile ocular blood flow in primary open-angle glaucoma patients.
    Janulevicienë I; Harris A; Kagemann L; Siesky B; McCranor L
    Acta Ophthalmol Scand; 2004 Dec; 82(6):730-7. PubMed ID: 15606472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effectiveness and tolerance of metipranolol--results of a multi-center long-term study in Switzerland].
    Müller O; Knobel HR
    Klin Monbl Augenheilkd; 1986 Jan; 188(1):62-3. PubMed ID: 2870216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Low-pressure Glaucoma Treatment Study (LoGTS) study design and baseline characteristics of enrolled patients.
    Krupin T; Liebmann JM; Greenfield DS; Rosenberg LF; Ritch R; Yang JW;
    Ophthalmology; 2005 Mar; 112(3):376-85. PubMed ID: 15745762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of daily instillations of timolol on the nycthemeral tension in subjects with chronic open-angle glaucoma (author's transl)].
    Demailly P; Pigot C; Arrata M
    J Fr Ophtalmol; 1978 Dec; 1(12):739-42. PubMed ID: 155099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circadian intraocular pressure control with dorzolamide versus timolol maleate add-on treatments in primary open-angle glaucoma patients using latanoprost.
    Tamer C; Oksüz H
    Ophthalmic Res; 2007; 39(1):24-31. PubMed ID: 17164574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.